We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$2.9B
AUM Growth
-$1.19B
Cap. Flow
-$1.27B
Cap. Flow %
-43.75%
Top 10 Hldgs %
34.83%
Holding
644
New
132
Increased
85
Reduced
129
Closed
248

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$44.7M
2
PLD icon
Prologis
PLD
+$36.2M
3
DFS
Discover Financial Services
DFS
+$35.3M
4
TFC icon
Truist Financial
TFC
+$32M
5
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$28.4M

Top Sells

Rank Stock Value
1
SNV
Synovus
SNV
+$27.8M
2
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$25.2M
3
CIVI
Civitas Resources
CIVI
+$24.3M
4
KO icon
Coca-Cola
KO
+$23.5M
5
APC
Anadarko Petroleum
APC
+$22.2M

Sector Composition

Rank Sector Weight
1 Financials 21.26%
2 Real Estate 14.1%
3 Healthcare 6.11%
4 Industrials 4.83%
5 Technology 4.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBMD
326
CALL
DELISTED
WebMD Health Corp.
WBMD
$593K 0.02%
+15,000
New +$576K
TRAW icon
327
Traws Pharma
TRAW
$7.43M
$584K 0.02%
3
+1
+50% +$245K
RRTS
328
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$584K 0.02%
1,000
-5,000
-83% -$2.77M
TRUP icon
329
Trupanion
TRUP
$1.05B
$572K 0.02%
82,500
+35,000
+74% +$230K
TGTX icon
330
TG Therapeutics
TGTX
$8.58B
$570K 0.02%
36,000
+1,000
+3% +$13K
XBI icon
331
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$560K 0.02%
9,000
-51,000
-85% -$2.91M
CLVS
332
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$560K 0.02%
10,000
-5,000
-33% -$263K
GSAT icon
333
Globalstar
GSAT
$10.2B
$550K 0.02%
13,333
+3,333
+33% +$128K
CPHD
334
DELISTED
Cepheid Inc
CPHD
$541K 0.02%
10,000
-10,000
-50% -$506K
HOLX
335
CALL
DELISTED
Hologic
HOLX
$535K 0.02%
+20,000
New +$516K
LGND icon
336
Ligand Pharmaceuticals
LGND
$6.02B
$532K 0.02%
+16,030
New +$521K
ASPX
337
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$525K 0.02%
+10,000
New +$294K
DBI icon
338
Designer Brands
DBI
$277M
$522K 0.02%
+14,000
New +$457K
KTWO
339
DELISTED
K2M Group Holdings, Inc
KTWO
$522K 0.02%
25,000
+5,000
+25% +$86.5K
ARIA
340
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$515K 0.02%
75,000
+15,000
+25% +$93.8K
HTWR
341
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$514K 0.02%
7,000
+2,000
+40% +$152K
SGNT
342
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$502K 0.02%
20,000
-5,000
-20% -$147K
RIGL icon
343
Rigel Pharmaceuticals
RIGL
$680M
$499K 0.02%
22,000
+7,000
+47% +$142K
IL
344
DELISTED
IntraLinks Holdings Inc.
IL
$476K 0.02%
40,000
-10,000
-20% -$97.1K
CPRX
345
DELISTED
Catalyst Pharmaceutical
CPRX
$475K 0.02%
160,000
+10,000
+7% +$27.4K
RLYP
346
CALL
DELISTED
RELYPSA INC COM
RLYP
$462K 0.02%
+15,000
New +$357K
ITCI
347
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$441K 0.02%
25,000
-32,945
-57% -$515K
WCN
348
Waste Connections
WCN
$42.8B
$440K 0.02%
+15,000
New +$472K
CASC
349
DELISTED
Cascadian Therapeutics, Inc.
CASC
$437K 0.02%
38,333
+5,000
+15% +$54.3K
ABMD
350
DELISTED
Abiomed Inc
ABMD
$419K 0.01%
11,000
-9,000
-45% -$284K
12 13
14
15 16

Similar funds

SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
BC
Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return

Weiss Multi-Strategy Advisers's Q4 2014 Portfolio in Review

As of Q4 2014, Weiss Multi-Strategy Advisers held 644 positions worth $2.9B, down 29% from $4.09B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Weiss Multi-Strategy Advisers withdrew a net $1.27B in Q4 2014, closing 248 positions and reducing 129 holdings. Its most notable exit was Coca-Cola Europacific Partners, an estimated $25.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 12% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Weiss Multi-Strategy Advisers opened a new position in Capital One worth $45.4M.

  • Weiss Multi-Strategy Advisers's largest Q4 2014 buy was Capital One: 550,000 shares worth $45.4M.
  • Weiss Multi-Strategy Advisers added most to Prologis in Q4 2014, an estimated $36.2M increase.
  • Weiss Multi-Strategy Advisers's biggest Q4 2014 reduction was Synovus, cutting an estimated $27.8M.
  • Weiss Multi-Strategy Advisers fully exited Coca-Cola Europacific Partners in Q4 2014, selling an estimated $25.2M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 35% of its $2.9B portfolio in Q4 2014.
  • Weiss Multi-Strategy Advisers opened 132 new positions and closed 248 in Q4 2014.
  • Weiss Multi-Strategy Advisers's portfolio value fell 29% quarter-over-quarter to $2.9B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2014, filed 17 Feb 2015.